(Q53307784)

English

The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation.

scientific article published on 17 September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

Stephen J. Walters

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

1

object named as

James B Chilcott

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

author name string

Michael W Holmes

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

Ronald L Akehurst

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

Björn Nashan

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

publication date

17 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

Transplant International

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

15

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

9-10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

486-493

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

Calcium channel blockers: what they can and what they can't do.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2002.TB00204.X

21 January 2018

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2002.TB00204.X

21 January 2018

DETERMINANTS OF GRAFT SURVIVAL AFTER RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2002.TB00204.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2002.TB00204.X

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/12389081

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53307784&oldid=2048707685"